Publication | Closed Access

A multicentred phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150 mg: II. The comparison of bleeding patterns

Hormonal ContraceptiveDepot-medroxyprogesterone AcetateMedicineBleeding PatternsGynecologyPharmacotherapyPharmacologyAnesthesiologyMenopause Hormone Therapy